Government Agencies

Health Andrew Joseph

New CDC opioid guidelines emphasize flexibility in treating pain

Politics Nicholas Florko

FDA, DOJ sue 6 vape shops for ignoring warnings about selling illegal products

Politics Sarah Owermohle

Biden officials search for backup for key Covid therapy for immunocompromised people

Insurance Bob Herman

Bright exits ACA health insurance marketplaces to stay afloat

Politics Sarah Owermohle

White House directs health, science agencies to make federally funded studies free to access

Pharmalot Ed Silverman

Major Indian generic drugmaker closes a U.S. facility after years of manufacturing problems

Health Associated Press

Over-the-counter hearing aids expected this fall in U.S.

Health Tech Katie Palmer

The FDA’s ‘breakthrough’ medical devices are finally hitting the market in numbers

Politics Lev Facher

Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why

First Opinion Kenneth E. Thorpe

WTO: Don’t make a bad situation worse by granting intellectual property waivers for Covid-19 therapeutics and diagnostics

Pharmalot Ed Silverman

FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street

First Opinion Kira Sampson, Carlise Sorenson and Kate Adamala

The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeutics

Pharmalot Ed Silverman

‘No magic bullet’: For drugmakers and the FDA, clinical trials on ultra-rare diseases pose thorny challenges

Pharmalot Ed Silverman

Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs

Pharmalot Ed Silverman

Federal patent initiatives could cause ‘headwinds’ for drugmakers and their broad filings

First Opinion Kushal T. Kadakia, Sanket S. Dhruva and Harlan M. Krumholz

For safety’s sake, it’s time to get medical device identifiers over the finish line

Pharmalot Ed Silverman

‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.

Health Associated Press

Drugmaker seeks FDA approval of over-the-counter birth control pill

Politics Nicholas Florko

FDA appears to hold off on crackdown on synthetic nicotine products, despite calls from Congress

Exclusive Lev Facher

In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans

First Opinion Jorge A. Caballero

The FDA owes parents an explanation about why it delayed authorizing Moderna’s Covid-19 vaccine for young kids

First Opinion Paul Chaplin

The monkeypox vaccine underscores the value of U.S. investments in preparedness

First Opinion Michele Barry and Lawrence O. Gostin

Improve CDC’s quarantine stations to prevent the next pandemic

Health Helen Branswell

FDA panel to advise on whether — and how — Covid vaccines should be updated

Politics Nicholas Florko

government agencies

Most Read

A minuscule new HHS office has a mammoth goal: tackling environmental justice

European Commission says preliminary findings indicate Teva violated antitrust rules

Health plans say texting could help reach underserved patients. But a federal rule is getting in their way

In new guidance, FDA says AI tools to warn of sepsis should be regulated as devices

FDA rule would facilitate prescription-to-OTC switches but nix a third class of drugs

FDA: Don’t rush a move to change the Covid-19 vaccine composition

Flawed FDA safety requirements are hamstringing a highly effective treatment for severe schizophrenia

HHS needs to step up so CDC’s new guidelines won’t be ‘a bridge to nowhere’ for most Americans living with chronic pain

All Coverage

New CDC opioid guidelines emphasize flexibility in treating pain

FDA, DOJ sue 6 vape shops for ignoring warnings about selling illegal products

Biden officials search for backup for key Covid therapy for immunocompromised people

Bright exits ACA health insurance marketplaces to stay afloat

White House directs health, science agencies to make federally funded studies free to access

Major Indian generic drugmaker closes a U.S. facility after years of manufacturing problems

Over-the-counter hearing aids expected this fall in U.S.

The FDA’s ‘breakthrough’ medical devices are finally hitting the market in numbers

Cities are lobbying to host the ARPA-H headquarters. Experts don’t understand why

WTO: Don’t make a bad situation worse by granting intellectual property waivers for Covid-19 therapeutics and diagnostics

FDA’s decision to review a Biogen ALS drug is met with skepticism and uncertainty on Wall Street

The FDA needs to get ready to evaluate synthetic cells, the next generation of therapeutics

‘No magic bullet’: For drugmakers and the FDA, clinical trials on ultra-rare diseases pose thorny challenges

Pfizer loses another court battle alleging the U.S. illegally limits use of copay assistance programs

Federal patent initiatives could cause ‘headwinds’ for drugmakers and their broad filings

For safety’s sake, it’s time to get medical device identifiers over the finish line

‘Eye-opening’: The Covid-19 pandemic accelerated antimicrobial resistance across the U.S.

Drugmaker seeks FDA approval of over-the-counter birth control pill

FDA appears to hold off on crackdown on synthetic nicotine products, despite calls from Congress

In the search for an ARPA-H director, the White House is zeroing in on DARPA veterans

The FDA owes parents an explanation about why it delayed authorizing Moderna’s Covid-19 vaccine for young kids

The monkeypox vaccine underscores the value of U.S. investments in preparedness

Improve CDC’s quarantine stations to prevent the next pandemic

FDA panel to advise on whether — and how — Covid vaccines should be updated

The Biden administration wants to get tough on states’ abortion pill restrictions. It won’t be easy

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day